Compoundeer Logo
COMPOUNDEER
Uncovering Potential
RankingCompaniesDCF
PFE Logo

Pfizer Inc

PFE

Pharmaceutical Preparations

Mkt Cap

$145.9B

PE

68.87

Debt

$71.89B

Cash

$2.917B

EV

$214.9B

FCF

$4.793B

Market Cap

$145.9B

P/E Ratio

68.87

Debt

$71.89B

Cash

$2.917B

EV

$214.9B

FCF

$4.793B
Charts data: {"Earnings":[{"time":"2014-12-30","value":9134000000},{"time":"2015-12-30","value":6959000000},{"time":"2016-12-30","value":7214000000},{"time":"2017-12-30","value":21307000000},{"time":"2018-12-30","value":11152000000},{"time":"2019-12-30","value":16272000000},{"time":"2020-12-30","value":9616000000},{"time":"2021-12-30","value":21979000000},{"time":"2022-12-30","value":31372000000},{"time":"2023-12-30","value":2119000000}],"Sales":[{"time":"2014-12-30","value":49605000000},{"time":"2015-12-30","value":48851000000},{"time":"2016-12-30","value":52824000000},{"time":"2017-12-30","value":52546000000},{"time":"2018-12-30","value":53647000000},{"time":"2019-12-30","value":51750000000},{"time":"2020-12-30","value":41651000000},{"time":"2021-12-30","value":81288000000},{"time":"2022-12-30","value":100330000000},{"time":"2023-12-30","value":58496000000}],"Net Margins":[{"time":"2014-12-30","value":0.18413466384437052},{"time":"2015-12-30","value":0.14245358334527441},{"time":"2016-12-30","value":0.13656671210056034},{"time":"2017-12-30","value":0.4054923305294409},{"time":"2018-12-30","value":0.2078774209182247},{"time":"2019-12-30","value":0.3144347826086957},{"time":"2020-12-30","value":0.23087080742359126},{"time":"2021-12-30","value":0.27038431256766066},{"time":"2022-12-30","value":0.3126881291737267},{"time":"2023-12-30","value":0.03622469912472648}],"Assets":[{"time":"2014-12-30","value":169274000000},{"time":"2015-12-30","value":167460000000},{"time":"2016-12-30","value":171615000000},{"time":"2017-12-30","value":171797000000},{"time":"2018-12-30","value":159422000000},{"time":"2019-12-30","value":167489000000},{"time":"2020-12-30","value":154229000000},{"time":"2021-12-30","value":181476000000},{"time":"2022-12-30","value":197205000000},{"time":"2023-12-30","value":226501000000}],"Stockholders Equity":[{"time":"2014-12-30","value":71622000000},{"time":"2015-12-30","value":64998000000},{"time":"2016-12-30","value":59840000000},{"time":"2017-12-30","value":71656000000},{"time":"2018-12-30","value":63758000000},{"time":"2019-12-30","value":63447000000},{"time":"2020-12-30","value":63473000000},{"time":"2021-12-30","value":77462000000},{"time":"2022-12-30","value":95916000000},{"time":"2023-12-30","value":89288000000}],"ROE":[{"time":"2014-12-30","value":0.1275306470079026},{"time":"2015-12-30","value":0.10706483276408504},{"time":"2016-12-30","value":0.1205548128342246},{"time":"2017-12-30","value":0.2973512336719884},{"time":"2018-12-30","value":0.1749113836695003},{"time":"2019-12-30","value":0.2564660267624947},{"time":"2020-12-30","value":0.15149748712050792},{"time":"2021-12-30","value":0.2837391236993623},{"time":"2022-12-30","value":0.3270778597939864},{"time":"2023-12-30","value":0.02373219245587313}],"ROA":[{"time":"2014-12-30","value":0.08034311235039049},{"time":"2015-12-30","value":0.060695091365102115},{"time":"2016-12-30","value":0.05557206537890044},{"time":"2017-12-30","value":0.07162523210533361},{"time":"2018-12-30","value":0.07455056391213258},{"time":"2019-12-30","value":0.10557111213273708},{"time":"2020-12-30","value":0.048609535171725164},{"time":"2021-12-30","value":0.13396261764641054},{"time":"2022-12-30","value":0.17610608250297913},{"time":"2023-12-30","value":0.004671061054918079}]}

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Sector

  • ABBV Logo

    ABBV

  • ABCL Logo

    ABCL

  • ABT Logo

    ABT

  • ABUS Logo

    ABUS

  • AGIO Logo

    AGIO

  • AKRO Logo

    AKRO

  • ALKS Logo

    ALKS

  • ALNY Logo

    ALNY

  • ALPN Logo

    ALPN

  • AMPH Logo

    AMPH

  • AMRN Logo

    AMRN

  • AMRX Logo

    AMRX

  • ANAB Logo

    ANAB

  • ANIP Logo

    ANIP

  • APLS Logo

    APLS

  • ARCT Logo

    ARCT

  • ARDX Logo

    ARDX

  • ARQT Logo

    ARQT

  • ARVN Logo

    ARVN

  • ARWR Logo

    ARWR

  • ATAI Logo

    ATAI

  • AUPH Logo

    AUPH

  • AVDL Logo

    AVDL

  • AVIR Logo

    AVIR

  • AVTE Logo

    AVTE

  • AXSM Logo

    AXSM

  • BBIO Logo

    BBIO

  • BCYC Logo

    BCYC

  • BGNE Logo

    BGNE

  • BHVN Logo

    BHVN

  • BMEA Logo

    BMEA

  • BMRN Logo

    BMRN

  • BMY Logo

    BMY

  • BPMC Logo

    BPMC

  • CBAY Logo

    CBAY

  • CDMO Logo

    CDMO

  • CERE Logo

    CERE

  • CMPS Logo

    CMPS

  • CNTA Logo

    CNTA

  • COGT Logo

    COGT

  • COLL Logo

    COLL

  • CORT Logo

    CORT

  • CPRX Logo

    CPRX

  • CRNX Logo

    CRNX

  • CTLT Logo

    CTLT

  • CYRX Logo

    CYRX

  • CYTK Logo

    CYTK

  • DAWN Logo

    DAWN

  • DCPH Logo

    DCPH

  • DVAX Logo

    DVAX

  • DYN Logo

    DYN

  • ELAN Logo

    ELAN

  • ENTA Logo

    ENTA

  • EOLS Logo

    EOLS

  • ERAS Logo

    ERAS

  • ETNB Logo

    ETNB

  • EWTX Logo

    EWTX

  • FHTX Logo

    FHTX

  • FOLD Logo

    FOLD

  • FULC Logo

    FULC

  • GERN Logo

    GERN

  • GPCR Logo

    GPCR

  • HRMY Logo

    HRMY

  • HROW Logo

    HROW

  • HZNP Logo

    HZNP

  • IDYA Logo

    IDYA

  • IGMS Logo

    IGMS

  • INSM Logo

    INSM

  • INVA Logo

    INVA

  • IONS Logo

    IONS

  • IRON Logo

    IRON

  • IRWD Logo

    IRWD

  • ITCI Logo

    ITCI

  • JANX Logo

    JANX

  • JAZZ Logo

    JAZZ

  • JNJ Logo

    JNJ

  • KALV Logo

    KALV

  • KNSA Logo

    KNSA

  • KROS Logo

    KROS

  • KRTX Logo

    KRTX

  • KURA Logo

    KURA

  • LGND Logo

    LGND

  • LLY Logo

    LLY

  • LQDA Logo

    LQDA

  • LXRX Logo

    LXRX

  • LYEL Logo

    LYEL

  • MDGL Logo

    MDGL

  • MGNX Logo

    MGNX

  • MIRM Logo

    MIRM

  • MLTX Logo

    MLTX

  • MNKD Logo

    MNKD

  • MORF Logo

    MORF

  • MRK Logo

    MRK

  • MRNS Logo

    MRNS

  • MRUS Logo

    MRUS

  • MRVI Logo

    MRVI

  • NATR Logo

    NATR

  • NRIX Logo

    NRIX

  • OCUL Logo

    OCUL

  • OGN Logo

    OGN

  • OLMA Logo

    OLMA

  • OPK Logo

    OPK

  • ORGO Logo

    ORGO

  • ORIC Logo

    ORIC

  • PAHC Logo

    PAHC

  • PBAJ Logo

    PBAJ

  • PBH Logo

    PBH

  • PCRX Logo

    PCRX

  • PGEN Logo

    PGEN

  • PHAT Logo

    PHAT

  • PLRX Logo

    PLRX

  • PRGO Logo

    PRGO

  • PRTA Logo

    PRTA

  • PTCT Logo

    PTCT

  • PTGX Logo

    PTGX

Growth

%

%

Discount

%

%

Multiple

g\r+10%+11%+12%+13%+14%
0%109887
+1%1110988
+2%13111098
+3%141311109
+4%1714121110
Years012345678910TV
FCF$4.793B$4.901B$5.011B$5.123B$5.238B$5.355B$5.476B$5.598B$5.724B$5.853B$5.984B$59.84B
DCF$4.261B$3.789B$3.368B$2.995B$2.663B$2.367B$2.105B$1.871B$1.664B$1.479B$14.79B
Value$41.35B

In the chart Earnings are multiplied by this value.

Earnings Growth 9.5%
Earnings Stability 16%


Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12-201512-201612-201712-201812-201912-202012-202112-202212-2023TTM
Net Margin14%14%41%21%31%23%27%31%3.6%3.6%
ROA6.1%5.6%7.2%7.5%11%4.9%13%18%0.47%0.47%
ROE11%12%30%17%26%15%28%33%2.4%2.4%

What is the average Net Margin?

The average Net Margin over the past 5 years is +22.87%.

What is the trend of Net Margin?

The trend of Net Margin over the past 5 years is -2.35%.

What is the average Return on Assets (ROA)?

The average ROA over the past 5 years is +9.06%.

What is the trend of Return on Assets (ROA)?

The trend of ROA over the past 5 years is -0.15%.

What is the average Return on Equity (ROE)?

The average ROE over the past 5 years is +20.29%.

What is the trend of Return on Equity (ROE)?

The trend of ROE over the past 5 years is -1.18%.


Safety & Stabiliy

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12-201512-201612-201712-201812-201912-202012-202112-202212-2023TTM
Debt FCF2.972.993.003.035.013.281.271.3815.0015.00
Debt Equity0.600.700.610.650.820.630.500.370.810.81
MIN
Graham Stability--100%94%100%59%100%100%10%10%

What is the Debt/FCF?

The Debt/FCF trailing twelve month is 15.00.

What is the trend of Debt/FCF?

The trend of Debt/FCF over the past 5 years is 1.34.

What is the Graham’s Stability?

Graham’s Stability measure stands at 0.10.


Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12-201612-201812-202012-2022Trend
Revenue1.5%1.7%12%-42%0.92%
Net Income-16%-28%-40%-93%-4.8%
Stockholders Equity5.9%7%12%-6.9%2%
FCF-14%-19%-27%-82%-0.19%

What is the 5 year Revenue CAGR?

The Revenue CAGR over the past 5 years is +1.75%.

What is the trend of Revenue growth?

The trend of Revenue growth rate over the past 5 years is +0.92%.

What is the 5 year Earnings CAGR?

The Earnings CAGR over the past 5 years is -28.26%.

What is the trend of Earnings growth?

The trend of Earnings growth rate over the past 5 years is -4.79%.

What is the 5 year Equity CAGR?

The Equity CAGR over the past 5 years is +6.97%.

What is the trend of Equity growth?

The trend of Equity growth rate over the past 5 years is +2%.

What is the 5 year FCF CAGR?

The FCF CAGR over the past 5 years is -19.05%.

What is the trend of FCF growth?

The trend of FCF growth rate over the past 5 years is -0.19%.